ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Akron Biotech, Octapharma enter Human AB Serum global production deal pharmaceutical-technology
January 22, 2021Akron Biotech has signed an exclusive global agreement with Switzerland-based Octapharma to produce virally inactivated Human AB Serum for the cell therapy market using the latter’s Octaplas. -
Fresenius Terminates $4.3-Billion Merger with Akron
americanpharmaceuticalreview
May 18, 2018Fresenius Kabi has decided to terminate the company’s previously announced merger agreement with Akorn, a United States-based manufacturer and marketer of prescription and over-the-counter pharmaceutical products.
Pharma Sources Insight January 2025
